| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 24,939 | 18,596 | 25,655 | 34,113 | | Cost of Revenue | 12,375 | 11,464 | 13,263 | 17,006 | | | Gross Profit | 12,564 | 7,132 | 12,392 | 17,107 | | | Operating Expenses | | Research Development | 4,573 | 4,458 | 5,177 | 5,722 | | Selling General and Administrative | 7,262 | 5,961 | 6,963 | 7,716 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 729 | (3,287) | 252 | 3,669 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | 2,748 | (45) | 343 | | Earnings Before Interest And Taxes | 747 | (539) | 207 | 4,012 | | Interest Expense | (293) | (10) | 10 | 12 | | Income Before Tax | 1,040 | (529) | 197 | 4,000 | | Income Tax Expense | (1) | (42) | 6 | 61 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,041 | (487) | 191 | 3,939 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,041 | (487) | 191 | 3,939 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,041 | ($487) | $191 | $3,939 |
|
0.51% Nasdaq 
Income Statement
